Tourmaline Bio(TRML)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

TRML Tourmaline Bio

盘后交易 07-22 19:23:17 EDT

15.41

+0.70

+4.76%

盘后15.40

-0.01-0.06%

18:05 EDT

最高15.48	最低14.19	成交量12.59万
今开14.72	昨收14.71	日振幅8.77%
总市值3.95亿	流通市值1.81亿	总股本2,565万
成交额187.85万	换手率1.07%	流通股本1,172万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"TRML","market":"US","secType":"STK","nameCN":"Tourmaline Bio","latestPrice":15.41,"timestamp":1721678400000,"preClose":14.71,"halted":0,"volume":125937,"hourTrading":{"tag":"盘后","latestPrice":15.4,"preClose":15.41,"latestTime":"18:05 EDT","volume":5486,"amount":84537.745864,"timestamp":1721685902321},"delay":0,"floatShares":11717992,"shares":25646509,"eps":-4.547291,"marketStatus":"盘后交易","marketStatusCode":4,"change":0.7,"latestTime":"07-22 19:23:17 EDT","open":14.72,"high":15.48,"low":14.19,"amount":1878500.471904,"amplitude":0.087695,"askPrice":15.72,"askSize":209,"bidPrice":14.32,"bidSize":1,"shortable":3,"etf":0,"ttmEps":-4.547291,"exchange":"NASDAQ","tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1721692800000},"adr":0,"listingDate":1620360000000,"adjPreClose":14.71,"preHourTrading":{"tag":"盘前","latestPrice":15.72,"preClose":14.71,"latestTime":"09:26 EDT","volume":27,"amount":409.449978,"timestamp":1721654766694},"postHourTrading":{"tag":"盘后","latestPrice":15.4,"preClose":15.41,"latestTime":"18:05 EDT","volume":5486,"amount":84537.745864,"timestamp":1721685902321},"volumeRatio":0.736272,"impliedVol":1.014,"impliedVolPercentile":0.4309},"requestUrl":"/m/hq/s/TRML/tweets","defaultTab":"tweets","newsList":[{"id":"2435859085","title":"电气石生物公司（Tourmaline Bio Inc）公布截至三月份的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2435859085","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435859085?lang=zh_cn&edition=full","pubTime":"2024-05-14 05:52","pubTimestamp":1715637143,"startTime":"0","endTime":"0","summary":"   * 电气石生物公司公布，在截至3月底的季度调整后每股亏损55美分，高于去年同期的每股收益5.40美元。六位分析师对该季度的平均预期是每股亏损 67 美分。华尔街预期为每股-96美分至-53美分。* Tourmaline Bio Inc 报告的本季度每股收益为亏损 55 美分。* 该公司当季亏损 1331 万美元。* 本季度，Tourmaline Bio Inc 的股价下跌了 36.7%，今年迄今为止下跌了 44.6%。* 生物技术与医学研究同行的平均一致建议是 \"买入\"。华尔街对电气石生物公司 12 个月目标价的中位数为 57.00 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","TRML"],"gpt_icon":0},{"id":"2421025459","title":"BUZZ-竞争对手中外制药的数据不尽如人意，Immunovant 和 Argenx 的业绩上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2421025459","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2421025459?lang=zh_cn&edition=full","pubTime":"2024-03-22 00:04","pubTimestamp":1711037051,"startTime":"0","endTime":"0","summary":"    3月21日 - ** 在日本中外制药公司  报告了其自身免疫性疾病药物satralizumab的后期数据后，Immunovant  的股价上涨2.5%至32.36美元，在美国上市的Argenx  的股价上涨12.3%至401美元。** 券商 Stifel 表示，由于该药物之前的研究数据令人印象深刻，因此该数据一直是 ARGX 和 IMVT 的主要障碍。** ARGX公司的Vyvgrat已被批准用于治疗这种疾病，而IMVT公司的实验性疗法正处于后期研究阶段。** Viridian Therapeutics    和 Tourmaline Bio    的股价分别下跌了 38.8% 和 38.8%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IMVT","VRDN","TRML","BUZZ"],"gpt_icon":0},{"id":"2421065650","title":"美国研究综述-Adobe、微软、ServiceNow","url":"https://stock-news.laohu8.com/highlight/detail?id=2421065650","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2421065650?lang=zh_cn&edition=full","pubTime":"2024-03-21 14:59","pubTimestamp":1711004360,"startTime":"0","endTime":"0","summary":"    路透社3月21日 - 华尔街证券分析师周四调整了对几家美国上市公司的评级和目标价，其中包括 Adobe、微软和 ServiceNow。* Hubspot Inc   ：KeyBanc给予其减持评级；目标价520美元 * 微软  ：KeyBanc给予增持评级；目标价490美元 * 诺福克南方公司  ：TD Cowen将目标价从236美元上调至253美元 * ServiceNow Inc   ：KeyBanc给予该公司 \"增持 \"评级，目标价1000美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AMRX","CHWY","SDHC","NOW","LU0289960550.SGD","KBH","LU0109391861.USD","IE0004445239.USD","LU1691799644.USD","ZI","BK4209","ASAN","MU","ADBE","BK4114","LU0068578508.USD","OABI","MSFT","OVV","SPT","NSC","OLLI","GIS","IE00B1BXHZ80.USD","EVEX","LU0661504455.SGD","SG9999001424.SGD","CRM","CMG","ORCL","CXM","AMPL","SEMR","HUBS","JANX","LU0878866978.SGD","SLRN","PR","H","NVDA","CROX","HII","LU0433182093.SGD","SM","TRML","LU0985489474.SGD","IE00B3S45H60.SGD","IE00BFSS8Q28.SGD","IE00BJTD4N35.SGD","NOG"],"gpt_icon":0},{"id":"2420798966","title":"美国研究综述-迪克体育用品、Nvidia、PVH","url":"https://stock-news.laohu8.com/highlight/detail?id=2420798966","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2420798966?lang=zh_cn&edition=full","pubTime":"2024-03-20 15:14","pubTimestamp":1710918896,"startTime":"0","endTime":"0","summary":"    路透社3月20日 - 华尔街证券分析师周三调整了对迪克体育用品公司、英伟达和 PVH 等几家美国上市公司的评级和目标价。股票条目按字母顺序排列。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ASO","LU0072462426.USD","SMPL","TNYA","IE00BMPRXN33.USD","BK4527","RLMD","SAIC","LU0053671581.USD","RAIL","DKS","CRNX","NVDA","SG9999002232.USD","LU0238689110.USD","BBIO","BK4213","SNDX","TRML","LU0889565916.HKD","BK4212","BK4588","PVH","CAL","DCPH","PLNT","LU0444971666.USD","BK4525","HQY","HPP","LU0731783394.SGD","BK4023","CSCO","RIOT","MTDR","BK4503","BK4505","BK4139","HLT","CNM","IE00BWXC8680.SGD","PTCT","BK4216","BK4543","LU0170899867.USD","GOCO","SG9999002224.SGD","RCM","BRO","LU1430594728.SGD"],"gpt_icon":0},{"id":"2420785693","title":"电气石生物公司（Tourmaline Bio Inc）报告截至 12 月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2420785693","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2420785693?lang=zh_cn&edition=full","pubTime":"2024-03-20 05:02","pubTimestamp":1710882125,"startTime":"0","endTime":"0","summary":"   * 电气石生物公司公布了截至12月底的季度调整后每股亏损81美分，高于去年同期的每股收益4.40美元。五位分析师对该季度的平均预期是每股亏损 77 美分。华尔街预期为每股亏损 1.18 美元至-37 美分。* Tourmaline Bio Inc 报告的季度每股收益为亏损 81 美分。* 该公司当季亏损 1290 万美元。* 本季度，Tourmaline Bio Inc 的股价上涨了 52.8%。* 生物技术与医学研究同行的平均一致建议是 \"买入\"。华尔街对电气石生物公司 12 个月目标价的中位数为 48.50 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TRML","BK4139"],"gpt_icon":0},{"id":"2406216393","title":"BUZZ-电气石生物公司股票发行价下跌 1.5 亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2406216393","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2406216393?lang=zh_cn&edition=full","pubTime":"2024-01-25 21:42","pubTimestamp":1706190153,"startTime":"0","endTime":"0","summary":"    1月25日 - ** Tourmaline生物公司  股价下跌2.8%，报35.00美元。** 该公司以 32.50 美元的价格出售  ~460 万股股票，募集资金总额为 1.5 亿美元，用于管道产品的持续临床开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BUZZ","TRML","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.tourmalinebio.com","stockEarnings":[{"period":"1week","weight":-0.0134},{"period":"1month","weight":-0.054},{"period":"3month","weight":-0.0479},{"period":"6month","weight":-0.5327},{"period":"1year","weight":-0.5208},{"period":"ytd","weight":-0.4381}],"compareEarnings":[{"period":"1week","weight":-0.0196},{"period":"1month","weight":0.0009},{"period":"3month","weight":0.1087},{"period":"6month","weight":0.138},{"period":"1year","weight":0.2141},{"period":"ytd","weight":0.155}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Tourmaline Bio, Inc.在特拉华州注册成立。该公司是一家处于后期阶段的临床生物技术公司，其使命是开发具有变革性的药物，极大地改善患有改变生命的免疫疾病的患者的生活。他们的先导项目TOUR006是一种抗IL-6抗体，它表现出不同的特性，包括对IL-6的高结合亲和力和自然较长的半衰期。迄今为止，TOUR006已在六项临床试验中对400多名自身免疫患者进行了研究。该公司计划开发治疗甲状腺眼病（TED）和动脉粥样硬化性心血管病（ASCVD）的TOUR006，分别作为其主要适应症和次要适应症，其他适应症正在考虑之中。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.107839},{"month":2,"riseRate":0.666667,"avgChangeRate":0.078254},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.012439},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.01978},{"month":5,"riseRate":0.333333,"avgChangeRate":0.003184},{"month":6,"riseRate":0.25,"avgChangeRate":-0.120245},{"month":7,"riseRate":0.25,"avgChangeRate":0.010261},{"month":8,"riseRate":0,"avgChangeRate":-0.146405},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.020595},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.197816},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.042914},{"month":12,"riseRate":0.666667,"avgChangeRate":0.09156}],"exchange":"NASDAQ","name":"Tourmaline Bio","nameEN":"Tourmaline Bio"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Tourmaline Bio(TRML)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Tourmaline Bio(TRML)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Tourmaline Bio,TRML,Tourmaline Bio股票,Tourmaline Bio股票老虎,Tourmaline Bio股票老虎国际,Tourmaline Bio行情,Tourmaline Bio股票行情,Tourmaline Bio股价,Tourmaline Bio股市,Tourmaline Bio股票价格,Tourmaline Bio股票交易,Tourmaline Bio股票购买,Tourmaline Bio股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Tourmaline Bio(TRML)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Tourmaline Bio(TRML)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}